Chris Verbacher, CEO, Sanofi says that the firm has been built so that it could grow without having to rely on research and development into...
You say the name of a stock, and Mad Money's Jim Cramer tells you whether to buy or sell.
Mad Money's Jim Cramer answers live viewer "tweets" and emails on stock and investment questions.
Pfizer is currently making the case for approval of its rheumatoid arthritis pill to the FDA Advisory Panel, reports CNBC's Seema Mody.
News |
COMPANY : Dolby Laboratories
Data is a real-time snapshot *Data is delayed at least 15 minutesGlobal Business and Financial News, Stock Quotes, and Market Data and Analysis
© 2012 CNBC LLC. All Rights Reserved.
